Compass Pathways - Public Comps and Valuation Multiples

Compass Pathways Overview

About Compass Pathways

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Founded

2020

HQ

Employees

166

Website

compasspathways.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$223M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Compass Pathways Financials

Compass Pathways has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Compass Pathways achieved revenue of n/a and an EBITDA of -$160M.

Compass Pathways expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Compass Pathways valuation multiples based on analyst estimates

Compass Pathways P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	n/a	n/a	XXX	XXX	XXX
Gross Profit	n/a	n/a	XXX	XXX	XXX
Gross Margin	NaN%	NaN%	XXX	XXX	XXX
EBITDA	-$124M	-$160M	XXX	XXX	XXX
EBITDA Margin	-Infinity%	-Infinity%	XXX	XXX	XXX
Net Profit	-$98.3M	-$127M	XXX	XXX	XXX
Net Margin	-Infinity%	-Infinity%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Compass Pathways Stock Performance

As of April 25, 2025, Compass Pathways's stock price is EUR 4 (or $4).

Compass Pathways has current market cap of EUR 325M (or $349M), and EV of EUR 208M (or $223M).

See Compass Pathways trading valuation data

Compass Pathways Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$223M	$349M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Compass Pathways Valuation Multiples

As of April 25, 2025, Compass Pathways has market cap of $349M and EV of $223M.

Compass Pathways's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Compass Pathways's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Compass Pathways and 10K+ public comps

Compass Pathways Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$223M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	-1.4x	XXX	XXX	XXX
P/E	-2.1x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-1.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Compass Pathways Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Compass Pathways Valuation Multiples

Compass Pathways's NTM/LTM revenue growth is n/a

Compass Pathways's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.0M for the same period.

Over next 12 months, Compass Pathways's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Compass Pathways's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Compass Pathways and other 10K+ public comps

Compass Pathways Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	29%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	$1.0M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	n/a	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry